cover image - Mosby's 2025 Nursing Drug Reference - Elsevier E-Book on VitalSource, 38th Edition
ISBN: 9780443122026
Copyright: 2025
Publication Date: 08-01-2024
Page Count: 1536
Imprint: Mosby
List Price: $42.99

Mosby's 2025 Nursing Drug Reference - Elsevier E-Book on VitalSource, 38th Edition

by Linda Skidmore-Roth, RN, MSN, NP

Elsevier eBook on VitalSource

cover image - Mosby's 2025 Nursing Drug Reference - Elsevier E-Book on VitalSource, 38th Edition
ISBN: 9780443122026
Copyright: 2025
Publication Date: 08-01-2024
Page Count: 1536
Imprint: Mosby
List Price: $42.99
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Education Solutions Consultant.
An Access Code
Important note
This is a Faculty Product!
Any student who attempts to request a review copy will be reported to the school's faculty and administration.
Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2025 Nursing Drug Reference makes it easy to find the most vital information on the drugs that nurses administer most frequently. More than 5,000 drugs are profiled — including more than 25 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. Adding more drug monographs and resources on Evolve, Mosby’s NDR proves there is a difference in drug guides. It’s Mosby’s bestselling drug reference for nurses!
    • NEW! Drug monographs for more than 25 newly released, FDA-approved medications equip users with the latest drug information including generic names, trade names, pronunciations, do-not-confuse drugs, action, uses, contraindications, precautions, dosages and routes, side effects, pharmacokinetics, interactions (including drug/herb, drug/food and drug/lab test), nursing considerations, treatment of overdose, patient/family teaching, and more.
    • NEW! Several online-only drug monographs are added to the companion Evolve website, creating an overall total of more than 100 Evolve-only drug monographs for lesser-used medications.
    • NEW! Combinations heading for selected monographs highlight common combinations.
    • More than 5,000 generic and trade-name drugs are profiled, covering almost every drug that users will administer in practice or in clinicals.
    • Alphabetical organization by generic name provides quick and easy access to specific drugs, with both trade and generic names listed in the index.
    • Bolded coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities.
    • Nursing Process steps are used as the framework for organizing all nursing care information.
    • Complete pharmacokinetic information is summarized in a table and includes the mechanism and absorption of the drug as well as its action, duration, and excretion.
    • Side effects information is organized by body system and identified as common or life threatening, showing signs to watch for during assessments.
    • High Alert headers highlight drugs that pose the greatest risk if administered improperly.
    • Black Box Warnings provide alerts to FDA warnings of dangerous or life-threatening drug reactions.
    • Overview of drug categories explains the safe administration of common classes of drugs, as well as their common side effects and interactions.
    • Flexible, water-resistant cover provides durability in the clinical setting.
  • INDIVIDUAL DRUG MONOGRAPHS
    APPENDICES
    A. Selected New Drugs
    avacincaptad pegol
    bexagliflozin
    bimekizumab
    capivasertib
    daprodustat
    efbemalenograstim
    eflornithine
    elacestrant
    elranatamab
    epcoritamab
    etrasimod
    exagamglogene
    fezolinetant
    fruquintinib
    ganaxolone
    gepirone
    glofitamab
    iptacopan
    lecanemab
    toripalimab
    lotilaner
    lovotibeglogene autotemcel
    maralixibat
    maribavir
    mavacamten
    mirikizumab
    mitapivat
    momelotinib
    motixafortide
    nedosiran
    nirmatrelvir/ritonavir
    nirogacestat
    nirsevimab-alip
    perfluorohexyloctane
    pirtobrutinib
    quizartinib
    repotrectinib
    retifanlimab
    rezafungin
    rozanolixizumab-noli
    somatrogon-ghla
    sulbactam/durlobactam
    talquetamab
    tapinarof
    tofersen
    toripalimab
    vamorolone
    velmanase
    zavegepant
    zilucoplan
    zuranolone
    B. Ophthalmic, Nasal, Topical, and Otic Products
    C. Vaccines and Toxoids
    D. Recent FDA Drug Approvals

    INDEX
    EVOLVE WEBSITE
  • Linda Skidmore-Roth, RN, MSN, NP, Consultant, Littleton, Colorado; Former Nursing Faculty, New Mexico State University, Las Cruces, New Mexico; El Paso Community College, El Paso, Texas, USA
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Education Solutions Consultant.
An Access Code
Important note
This is a Faculty Product!
Any student who attempts to request a review copy will be reported to the school's faculty and administration.